Oncoplastic Care: How Breast and Plastic Surgeons Share One Operation
In oncoplastic surgery, a breast surgeon and a plastic surgeon plan one operation together — cancer control first, shape considered from the start.
Breast cancer surgery once handed patients a fixed sequence: remove the cancer first, think about appearance later, often in a different hospital. Oncoplastic surgery folds that sequence into one coordinated plan. The term covers operations in which cancer removal and reconstructive technique are designed together, frequently within a single anesthesia.
The model rests on a division of labor between two specialties. Understanding who does what — and where the handoffs happen — helps patients read their own care path. How the collaboration is organized varies between hospitals, and each patient’s plan involves individual variation.
Two specialties, one operating table
The breast surgeon owns the cancer side of the operation: locating the tumor, removing it with a margin of healthy tissue and assessing lymph nodes. The plastic surgeon owns the form side: rearranging remaining tissue after a lumpectomy, reducing and lifting to restore symmetry, or beginning full reconstruction after a mastectomy. In an oncoplastic case, both plans are drawn before the first incision.
The order inside the operating room follows the priority: cancer control first, then shape. The oncologic resection is completed and checked before reconstructive steps begin, and if findings during surgery change the picture, the reconstructive plan adapts. The two surgeons may operate in sequence or, at some stages, side by side.
Where pathology steers the plan
Oncoplastic surgery does not change a basic rule of cancer care: the microscope has the final word. Margins from the resection are examined by pathologists, and a positive margin can mean returning for more tissue even after a reconstruction has been shaped. Biopsy and margin test results need medical interpretation, and the wider team — oncologists, radiologists, pathologists — reads them together in tumor-board discussions.
This is why oncoplastic teams talk about sequencing radiation and chemotherapy from the outset. Reconstructive choices made on day one are chosen to hold up under the treatments that follow, or to leave room for them. The collaboration is less a single event than a standing channel between departments across the whole treatment arc.
What patients gain, and what to ask
The practical gains are fewer anesthesia events, a schedule built as one arc instead of two, and appearance treated as part of treatment rather than an afterthought. The trade-offs are real too: a combined operation is longer, the recovery period covers both the cancer and reconstructive work, and the possibility of side effects — bleeding, infection, wound-healing problems, changes in sensation — spans both parts. Staged surgery remains the sounder choice in some situations.
Reasonable questions for the care team: which surgeon handles which part, how margins are checked, and what happens to the reconstructive plan if pathology brings a surprise. Patients are entitled to consultations with both a board-certified breast surgeon and a board-certified plastic surgeon before agreeing to a combined plan. How the two sets of answers fit together is itself useful information about the team.
Before your consultation
- Ask which parts of the operation each surgeon performs.
- Confirm how margin results could change the plan after surgery.
- Ask how radiation or chemotherapy sequencing shaped the reconstructive choice.
- Meet both specialists separately before agreeing to a combined operation.
- Ask whether a staged approach was considered for your case and why.
MediIndex articles are for general information only and are not medical advice, diagnosis, or advertising. Outcomes vary by individual — consult a board-certified specialist for personal decisions.
